Thinking Bigger, Acting Bolder
ANNUAL REPORT 2024
We turned bold visions into action as we worked toward our goal of converging clinical research with patient care.
This mission is deeply personal to me.
Years ago, I lost my father. I often wonder if a clinical trial could have changed the outcome.
This drives my passion for our work, and I’m delighted by our progress over the past year.
We are committed to improving the experience for every patient waiting for a breakthrough.
Together, we’re building a better future for clinical research.
One that is more connected, efficient and
patient-centered.
“Every patient waiting for a breakthrough fuels our mission to transform clinical research.”
We’re thinking bigger, addressing systemic challenges and accelerating innovation.
At TransCelerate, we strive to:
Seamlessly connect clinical research and patient care
Make vital trial information easily accessible
Deliver life-saving medicines faster and safer
Our approach combines rapid improvements for immediate implementation with long-term solutions to transform the R&D ecosystem.
Transforming Connectivity
Redefining how research
and care interact
Information
Sharing & Reuse
Leveraging existing data
for faster discoveries
Innovative
Trial Design
Putting patients at the heart of clinical trials
Since 2012, we’ve grown from a startup team with five initiatives to a transformative force in biopharma R&D.
member companies
tools and solutions
in progress
toolkits delivered
benefits realized
Efficiency
Faster, more streamlined processes
Quality
Higher standards to enhance clinical trial integrity
Speed
Quicker delivery of
treatments to patients
Experience
Enhanced experiences for both patients and researchers
Our board of directors balances visionary ambition with practical execution, guiding us to take on bold challenges while delivering tangible outcomes.
“The mission of TransCelerate and the role we can collectively play in advancing positive change has never been more important. With the strategic direction that we have set and our track record of delivering tangible, meaningful solutions, I am extremely confident about what we can accomplish next.”
Robert Metcalf
Group Vice President, CDDA,
China & Japan Medical, Eli Lilly & Co.
Our member companies are at the core of TransCelerate’s success.
each year to bring new medicines to market.
They report more than 700 benefits across key categories, including:
“TransCelerate has really become part of our language at Amgen. Any of my colleagues here today would emphatically agree: the collaboration with TransCelerate has changed how we work as a company."
Narimon Honarpour,
M.D., Ph.D.,
Senior Vice President,
Global Development at Amgen
CHALLENGE
Inefficient data flow slows the delivery
of new and potentially life-saving treatments to patients.
CHALLENGE
Missed opportunities to advance scientific decision-making due to the siloed nature of existing data.
CHALLENGE
Global regulatory complexity can hinder efficient safety monitoring and timely treatment delivery.
CHALLENGE
Traditional clinical trials and regulatory complexity regarding real-world evidence limit the application of research to patient-focused care.
CHALLENGE
Complicated protocols and burdensome visits can make clinical trials less patient-friendly, limiting diversity and real-world insights.
The work is important, filled with victories and setbacks, but our resilience and belief keeps us moving forward.
In 2024, we forged partnerships that are redefining collaboration across R&D.
EU Patient-Centric Clinical Trial Platforms
Partnering with European health consortium to simplify approach to patient-friendly platform trials
Association of Clinical Research Organizations (ACRO)
Co-creating tools to support the implementation of new Good Clinical Practice guidelines around the world
Clinical Data Interchange Standards Consortium (CDISC)
Accelerating development of clinical data exchange standards for protocol digitization
Implemented a holistic approach to engage with health authorities worldwide
Actively participated with health authorities at conferences and public events
Advanced knowledge and educated health authorities through sharing of insights, learnings and data
10 public webinars reached
4,000+ professionals
White papers tackled everything from decentralized trials to real-world data
Featured in top publications from DIA Global Forum to Applied Clinical Trials
In 2024, we shared our voices at over 40 leadership-level events across 27 cities and 12 countries.
As TransCelerate looks ahead, we’re exploring the transformative movements that have the potential to reshape biopharma R&D. This includes technological advancements enabling better data interoperability, improved data quality and risk detection and the expansion of access to treatment through the convergence of clinical research and care.
Together, we’re building a more efficient, patient-centered future for clinical research.
For a deeper dive into our work, download our full report here.